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Abstract. Breast cancer is the most kind of cancer  that happens to women, and it’s one of 
the cancer that can cause the major death in the world and in Indonesia. Breast cancer cases 
at age are very young tend to have lower percentages of old age, but have a bad prognosis. 
Family history of breast cancer because of the BRCA1 and BRCA2 mutation . Objective. The 
aim of this research is to study about breast cancer very young age profile in H. Adam Malik 
Medan General Hospital. From 2016-2018 based on age, family history and grading 
histology. Methods. In this descriptive research with cross-sectional study, the sample were 
collected from medical record of breast cancer patient in H. Adam Malik Medan General 
Hospital. This research use total sampling method and matched with inclusion and exclusion 
criteria. Results. Total of the sample is 160 subject. The majority of age group is 31-35 year’s 
old (81 subject or 51,0%). The majority of age menarche group is <12 year’s old (104 subject 
or 65,5%). Do not have family history (82 subject or 51,3%), and have a family history just 
found (78 subject or 48,8%). The majority of grading histology is grade 3 (68 subject or 
42,5%). Conclusion. Sufferers of breast cancer at very young age is quite a lot with grade 3 
on grading histology.    
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1. Introduction  
Breast cancer is breast malignancy coming and derived from ductal epithelial cells and their 
lobules [1]. Breast cancer is one of the most common malignance among women, but less than 
2% occur in women younger than 35 years old [2]   
In normal condition estrogen hormone can affect the growth and development of a women’s breast 
tissue during the reproductive age, start from puberty until menopause and during the pregnancy 
phase. Estrogen hormone also can affect the growth and development of breast cancer which will 
stimulate the production of growth factors such as transformation (transforming growth factor-a) 
and other factors that will trigger tumor development through paracrine and autocrine mechanism 
[3].  
In a Portuguese study in 2017, patients under 35 years old from all breast cancer, 5% is occur in 
women under 35 years old, making it the most common cancer in women of this age group. About 
tumor subtype, 20% is triple negative, 28% is HER2 positive [4]. There are many factors related 
with breast cancer, mostly related with women reproductive history and hormonal exposure in 
their whole life. These factors include age, age at menarche, age at menopause, first gestational, 
long breastfeeding status, alcohol consumption, body mass index (IMT) and women with a family 
history of BRCA 1 and BRCA 2 gene mutations have an increased risk [5].  
According to Basic Health Research, breast cancer has the second highest prevalence in Indonesia 
in 2013 which was 0.5%, while in North Sumatra the prevalence of breast cancer was estimated 
at 2.682 people (0.4%) [6]. Data about the breast cancer profile in young women still very rare in 
Indonesia, especially in North Sumatra, Medan. Therefore, researcher is interested in knowing the 
profile of breast cancer in young woman at Haji Adam Malik Hospital Medan.  
2. Method  
Collecting data is done by collecting secondary data sourced from medical records of breast cancer 
patients at Haji Adam Malik Hospital Medan 2016-2018 period. This research was conducted 
from March to December 2019. The method used is descriptive approach crosssectional and 
consecutive sampling which all breast cancer patient who met the inclusion criteria as many 160 
patients.  
Characteristics of the sample taken based on clinical features (age group, menarche age, family 
history) and histological grading. This research has received permission from the Medical Faculty 
Ethic Commission of the University of Sumatera Utara Medan No: 152/TGL/KEPK FK USU-
RSUP HAM/2019 August 8th, 2019.    
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3. Result  
Medical record data that has been collected then analyzed so the result obtained in the frequency 
distribution based on clinical features can be seen in Table 1 below:   
 
Tabel 1 Distribution Frequency of Age Group, Menarche, Family History  
 Age Group    Frequency (n)   Percentage (%)  
    <20 Age     1      0.6  
    21-25 Age    28      23,7  
    26-30 Age    50      31,0  
    31-35 Age    81      51,0  
Age of menarche   Frequency (n)    Percentage (%)  
    <12 Age    104      65,5   
    13-15 Age    52      32,5  
    >15 Age    4      2,5  
Family History    Frequency(n)    Percentage (%)  
    Yes                 78      48,8  
    No       82      51,3  
   Total     160      100  
  
Histological grading is a score that tells the difference growth of cancer cells from normal and 
healthy, can be seen in Table 2 below:  
  
Tabel 2 Distribution of Grading Histologi  
 Grading Histology     Frequency (n)    Percentage(%)  
  Grade 1  31  19,4  
  Grade 2  61  38,1  
  Grade 3  68  42,5   
     Total                     160                        100  
4. Discussion  
Based on the age group of breast cancer patients in young women (table 1), most found in the 
group age 31 years old until – 35 years old as many (51.0%) of 81 patients, following by age 
group 26 years old - 30 years old (31.0%: 50 patients), 21 years old – 25 years old (23.7%: 28 
patients) while the age group under 20 years old there are only (0.6%) of 1 patient. The results of 
this research are same as Georgeta and Maria’s research (2014) [7] which stated in every year it 
increases 2% breast cancer patients at young age and the data on 132 young women patients 
diagnosed with breast cancer at a young age of 31 years old (24 years old- 35 years old: 46%), 
and then Nasution (2018) [8] also conducted the research at Haji Adam Malik Hospital Medan, 
there are (9.8%) of 116 breast cancer patients under 35 years old.  
In addition, research on women in the United States is 0.2%, in young women under 20 years old 
affected by breast cancer and 0.5% at 30 years old (American cancer society, 2017) [9]. In 
Portugal also stated 5% tumor aggressiveness occurs in women with breast cancer under 35 years 
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old, and confirmed that higher percentage of aggressive tumor subtype occur at young age tend 
to be more HER2 positive and triple negative (European society for medical oncology, 2019) [10].  
Early menarche is included as a risk factor associated with breast cancer related with lifetime 
hormone exposure (Maria et al, 2019) [11]. Based on age group, early menarche in young age 
(Table 4) breast cancer patients which is most prevalent younger than 12 years old as many  
(65,6%) of 104 patients, following by age group 13 years old – 15 years old (32,5%: 52 patients), 
while the age group older than 15 years old there are only (2,5%) of 4 patients. Early menarche 
increase developing breast cancer in some women who menstruated for younger than 12 years old 
risky 1.7 – 2.4 higher than the women who menstruate at normal age. Menstruation before 11 
years old will increase the risk of breast cancer 3 times higher, and early menstruation also related 
with the length of exposure to the estrogen hormone which influences the process of tissue 
proliferation including breast tissue (kartikawati, 2013) [12].  
Family history also a risk factor related to breast cancer such as biological mother or biological 
sister. The most common cause of hereditary breast cancer is mutations inherited in the BRCA 1 
or BRCA 2 genes, around 5% until 10% cases of breast cancer are considered hereditary due to 
changes in genes, passed on from parents. Women with one of these mutations more tend to be 
diagnosed with breast cancer at young age, ovarian cancer, and several other types of cancer 
(American cancer society, 2019) [13]. Based on family history groups, breast cancer patients 
(48.8%) of 78 patients at a young age (table 1) had family history, and had no family history 
(51.3%) of 82 patients.  
Everyone has the BRCA1 and BRCA2 genes. Function of these genes is to repair damaged cells 
and maintain the breasts, ovaries, and other cells to grow normally. But, when these genes contain 
mutations handed down from generation to generation, these gens do not function normally in the 
breast, ovary, and other cancer risks (Maria, 2019) [14]. Sumadee et al (2019) [15] stated that 
breast cancer is a multifactorial disease. Genetic factors, environmental factors, and hormonal 
factors also can be a predisposing to malignancy. According to epidemiological research which is 
done in breast cancer, only 10% of all breast cancer cases involve genetic factors, while 90% of 
other breast cancer are caused by environmental factors, complex interactions between 
environmental factor and genetic factors influence the development of breast cancer.  
Histological grading (table 2) breast cancer patients at young age are the most in grade 3 (42.5%) 
of 68 patients, in grade 2 (38.1%) of 61 patients, and in grade 1 (19.4%) of 3 patients. Histological 
grading is done to see how bad the prognosis is in the breast cancer patients, and the woman who 
affected by breast cancer have a poor prognosis (dian and wayan, 2012) [16]. In (table 2) show 
that Grade 3 is the highest number in breast cancer patients. In Grade 1 or low grade (well 
differentiated) normal cells are still visible and the growth of new cancer cells is still slow. In 
Grade 2 or moderate grade (moderately differentiated) normal cells are increasingly invisible and 
the growth of cancer cells is slightly faster. In Grade 3 or high grade (poor differentiated) the 
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normal cells are no longer visible and the growth of cancer cells is very fast and abnormal (Maria, 
2017) [17].  
Negative estrogen receptors are many found at a younger age, younger women who have tumors 
with significant estrogen negative receptors and progesterone at a young age are present in Grade 
3. The tumor is more aggressive and the prognosis is worse and overexpression HER2/NEU. 
Overexpression HER2/NEU in tumors that develop at a younger age is considered a part of 
aggressive immunophenotype in cancer, especially lymph node metastasis (Eric et al., 2018) [18].  
5. Conclusion  
Breast cancer patient at younger age most found in the age group of 31 years old – 35 years old 
as many 81 patients, 104 patients with a history of menarche younger than 12 years old, 82 patients 
did not had a family history of breast cancer, and 72 patients had a family history of breast cancer. 
And 68 breast cancer patients at a young age are found more in high histological grading (Grade 




[1] International  Agency for Research Cancer. 2018, Breast Cancer. Accessed 20 March 2019. 
Available at: https://gco.iarc.fr/today/data/ factsheets/cancers/20-Breast-fact-sheet.pdf.  
[2] Georgeta, F. dan Maria, P. 2014, Breast cancer in young woman age 35 and under patterns 
of care and out come. Accessed 18 June 2019. Available at: 
https://ascopubs.org/doi/abs/10.1200/jco.2014.32.15_suppl.e11534.  
[3] Kumar, V., Abbas, A. K. dan Fausto, N. 2015, Robbins & Cotran Pathologic Basic of 
Disease 9th Edition. Elsevier, Singapore.  
[4] Lugano, S. 2018, 4th ESO-ESMO Breast Cancer in Young Women International Conference 
(BCY4), 6 - 8 October 2018. Accessed 18 June 2019. Available at: 
https://www.sciencedirect.com/journal/the-breast/vol/41/ suppl/S1.   
[5] Maria, C. W. 2019, Breast Cancer Risk Factor Genetic Accessed 19 November 2019.  
Available at: https://www.breastcancer.org/risk/factors/genetics.  
[6] Kementrian Kesehatan RI. 2015, Stop Kanker. Pusat Data dan Informasi Kementrian 
Kesehatan RI: Jakarta.  
[7] Georgeta, F. dan Maria, P. 2014, Breast cancer in young woman age 35 and under patterns 
of care and out come. Accessed 18 June 2019. Available at: 
https://ascopubs.org/doi/abs/10.1200/jco.2014.32.15_suppl.e11534.  
[8] Nasution, T. B. S. 2018, Perbedaan Nilai Tumor Infiltrating Lymphocytes (TILs) pada 
Subtipe Kanker Payudara Wanita Usia Sangat Muda di RSUPH. Adam Malik Medan. 
Medan: Universitas Sumatera Utara.  
[9] American Cancer Society. 2017, Cancer Facts and Figures 2017. Accesed 28 November 
2019. Available at: https://www.cancer.org /content/dam/ cancer-org/research/cancerfacts-
and-statistics/annual-cancer-facts-and-figures/2017/cancer-facts-and-figures2017.pdf.  
[10] European Society for Medical Oncology. 2019, Breast Cancer In Young Woman: Good 
Outcomes With Advised therapy. Accesed 17 november 2019. Available at: https://www. 
sciencedaily. com/releases/ 2019/04/ 190429182810.htm.  
[11] Maria, C. W. 2019, Breast Cancer Risk Factor Genetic Accessed 19 November 2019.  
Available at: https://www.breastcancer.org/risk/factors/genetics.  
[12] Kartika, W. dan Rani. 2013, Kanker Payudara, Yogyakarta. Salemba Medika.  
[13] American Cancer Society.  2019, Breast Cancer Risk Factors You Cannot Change. Accesed 
20 November 2019. Available at: https://www.cancer.org /content/dam/ cancer-
Sumatera Medical Journal (SUMEJ) Vol. 3, No.3, 2020                                                           6  
  
org/research/cancer-risk-factors-statistics/annual-cancer-risk-factors-you-
cannotchange/2019 /breast-cancer-risk-factors-you-cannot-change/2019.pdf.  
[14] Maria, T. M., Sara, S. O., Maria, P. C., Elisa, A., Cristina, H. dan Oktavio, B. 2019, Breast 
Cancer in Very Young Patients in a Spanish Cohort: Age as an Independent Bad Prognostic 
Indicator. Accessed 18 June 2019. Available at:   
https://journals.sagepub.com/doi/full/10.1177/ 1178223419828766.  
[15] Sumadee, D. S., Kamani, H. T., dan Eric, H. K. 2019, Overview of the Genetics Basis 
Toward Early Detection of Breast Cancer. Institute of Biochemistry, Molecular Biology and 
Biotechnology, University of Colombo, Colombo, Sri Lanka.  
[16] Dian, N. M. dan Wayan, I. S. 2012, Kanker Payudara pada Wanita USia Muda di Bagian 
Bedah Onkologi Rumah Sakit Umum Pusat Sanglah Denpasar Tahun 2002-2012. Denpasar: 
Fakultas Kedokteran Universitas Udayana.  
[17] Maria, C. W. 2017, Symptons and Diagnosis: Cell Grade. Accessed 20 November 2019. 
Available at: https:// www.breastcancer.org /symptoms/ diagnosis/ cell grade.   
[18] Eric, K., Marek, S., Peter, K., Marcela, N., Zuzana, L., Alena, L., Karol, D., Kamil, B. dan 
Denisa, S. 2018, Breast Cancer in Young Woman: Pathologic and Immunohistochemical 
Features. Accesed 20 November 2019. Available at:  
file:///C:/Users/ACER/ Downloads/13_eric_ 2017_015%20.pdf.  
  
